Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology, Interventional | 9 | 2024 | 483 | 2.780 |
Why?
|
Radiology | 15 | 2024 | 2117 | 2.430 |
Why?
|
Physicians, Women | 3 | 2024 | 520 | 1.370 |
Why?
|
Peripheral Arterial Disease | 4 | 2023 | 1303 | 1.190 |
Why?
|
Students, Medical | 5 | 2024 | 1964 | 1.090 |
Why?
|
Career Choice | 6 | 2024 | 769 | 1.040 |
Why?
|
Endovascular Procedures | 3 | 2024 | 2215 | 0.960 |
Why?
|
Venous Insufficiency | 1 | 2024 | 108 | 0.820 |
Why?
|
Lower Extremity | 4 | 2024 | 1218 | 0.770 |
Why?
|
Biomedical Research | 6 | 2024 | 3464 | 0.760 |
Why?
|
Peer Review | 1 | 2023 | 219 | 0.740 |
Why?
|
Porphyrins | 1 | 2023 | 352 | 0.730 |
Why?
|
Internship and Residency | 5 | 2024 | 5949 | 0.700 |
Why?
|
Appointments and Schedules | 3 | 2021 | 442 | 0.700 |
Why?
|
Congresses as Topic | 1 | 2024 | 810 | 0.670 |
Why?
|
Patient-Centered Care | 3 | 2024 | 1447 | 0.640 |
Why?
|
Comprehension | 1 | 2024 | 641 | 0.630 |
Why?
|
Artificial Intelligence | 7 | 2022 | 2661 | 0.590 |
Why?
|
Cryosurgery | 2 | 2022 | 477 | 0.570 |
Why?
|
Laser Therapy | 1 | 2024 | 1105 | 0.550 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2019 | 736 | 0.550 |
Why?
|
Radiology Department, Hospital | 4 | 2021 | 409 | 0.540 |
Why?
|
Ablation Techniques | 1 | 2019 | 255 | 0.540 |
Why?
|
Point-of-Care Systems | 2 | 2022 | 1238 | 0.510 |
Why?
|
Faculty, Medical | 3 | 2024 | 1218 | 0.500 |
Why?
|
Patient Education as Topic | 1 | 2024 | 2337 | 0.460 |
Why?
|
Consensus | 2 | 2023 | 3212 | 0.450 |
Why?
|
Research Personnel | 2 | 2017 | 590 | 0.440 |
Why?
|
Body Water | 1 | 2015 | 340 | 0.440 |
Why?
|
Venous Thrombosis | 1 | 2023 | 1317 | 0.440 |
Why?
|
Mammography | 3 | 2015 | 2434 | 0.430 |
Why?
|
Venous Thromboembolism | 2 | 2023 | 1881 | 0.430 |
Why?
|
Societies, Medical | 2 | 2024 | 3960 | 0.420 |
Why?
|
Magnetic Resonance Imaging | 14 | 2024 | 36849 | 0.410 |
Why?
|
Adipose Tissue | 2 | 2015 | 3334 | 0.410 |
Why?
|
Breast Neoplasms | 11 | 2023 | 21162 | 0.400 |
Why?
|
Subtraction Technique | 1 | 2015 | 519 | 0.390 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1188 | 0.390 |
Why?
|
Physicians | 4 | 2024 | 4614 | 0.390 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3413 | 0.370 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 1943 | 0.360 |
Why?
|
Catheters | 2 | 2023 | 427 | 0.350 |
Why?
|
Humans | 71 | 2024 | 768393 | 0.330 |
Why?
|
Hormones | 1 | 2013 | 870 | 0.320 |
Why?
|
Radiography | 5 | 2022 | 6993 | 0.320 |
Why?
|
Glutamine | 1 | 2012 | 578 | 0.310 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 2544 | 0.310 |
Why?
|
Patient Readmission | 1 | 2022 | 3312 | 0.300 |
Why?
|
Databases, Factual | 1 | 2024 | 8075 | 0.300 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2015 | 3411 | 0.290 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 1752 | 0.270 |
Why?
|
Pandemics | 5 | 2022 | 8753 | 0.270 |
Why?
|
Female | 39 | 2024 | 397089 | 0.270 |
Why?
|
Breast | 2 | 2015 | 1975 | 0.270 |
Why?
|
Radiography, Interventional | 2 | 2024 | 1131 | 0.270 |
Why?
|
Mentors | 2 | 2022 | 672 | 0.260 |
Why?
|
Atherosclerosis | 1 | 2022 | 3431 | 0.260 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4365 | 0.260 |
Why?
|
Health Services Accessibility | 4 | 2024 | 5512 | 0.250 |
Why?
|
Retrospective Studies | 15 | 2024 | 81801 | 0.240 |
Why?
|
Menopause | 1 | 2013 | 1653 | 0.240 |
Why?
|
Referral and Consultation | 3 | 2022 | 3627 | 0.230 |
Why?
|
Mammaplasty | 1 | 2014 | 1263 | 0.230 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3231 | 0.220 |
Why?
|
Treatment Outcome | 7 | 2024 | 65379 | 0.220 |
Why?
|
United States | 16 | 2024 | 73150 | 0.210 |
Why?
|
Polyurethanes | 1 | 2023 | 110 | 0.200 |
Why?
|
Faculty | 2 | 2022 | 384 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2846 | 0.200 |
Why?
|
Neoplasms | 4 | 2023 | 22385 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20765 | 0.190 |
Why?
|
Male | 22 | 2024 | 364902 | 0.190 |
Why?
|
Dissent and Disputes | 1 | 2022 | 150 | 0.190 |
Why?
|
Wounds, Penetrating | 1 | 2023 | 315 | 0.180 |
Why?
|
Manganese | 1 | 2023 | 394 | 0.170 |
Why?
|
Puerperal Disorders | 1 | 2022 | 303 | 0.170 |
Why?
|
Risk Factors | 8 | 2024 | 74962 | 0.160 |
Why?
|
Middle Aged | 20 | 2024 | 223491 | 0.160 |
Why?
|
New England | 1 | 2022 | 1058 | 0.160 |
Why?
|
Limb Salvage | 1 | 2022 | 489 | 0.160 |
Why?
|
Radiology Information Systems | 1 | 2023 | 533 | 0.160 |
Why?
|
Health Literacy | 1 | 2024 | 468 | 0.160 |
Why?
|
Thrombectomy | 1 | 2023 | 671 | 0.150 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 794 | 0.150 |
Why?
|
Device Removal | 1 | 2023 | 643 | 0.150 |
Why?
|
Aged | 15 | 2024 | 171562 | 0.150 |
Why?
|
Education, Medical | 2 | 2024 | 1742 | 0.150 |
Why?
|
Time Factors | 6 | 2024 | 40272 | 0.150 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2022 | 518 | 0.150 |
Why?
|
Awards and Prizes | 1 | 2022 | 365 | 0.150 |
Why?
|
Contrast Media | 3 | 2023 | 5336 | 0.140 |
Why?
|
Hydrogels | 1 | 2023 | 745 | 0.140 |
Why?
|
Education, Graduate | 1 | 2017 | 75 | 0.140 |
Why?
|
Practice Management, Medical | 1 | 2018 | 192 | 0.140 |
Why?
|
Adnexal Diseases | 1 | 2017 | 105 | 0.130 |
Why?
|
Mechanics | 1 | 2005 | 15 | 0.130 |
Why?
|
Quality of Health Care | 2 | 2022 | 4339 | 0.130 |
Why?
|
ROC Curve | 3 | 2019 | 3623 | 0.120 |
Why?
|
Adult | 15 | 2024 | 223640 | 0.120 |
Why?
|
Leadership | 2 | 2021 | 1395 | 0.120 |
Why?
|
Salicylates | 1 | 2005 | 128 | 0.120 |
Why?
|
Primary Health Care | 2 | 2022 | 4748 | 0.120 |
Why?
|
Hair Cells, Auditory, Outer | 1 | 2005 | 98 | 0.120 |
Why?
|
Fat Necrosis | 1 | 2014 | 60 | 0.120 |
Why?
|
Risk Assessment | 3 | 2023 | 24318 | 0.120 |
Why?
|
Thrombolytic Therapy | 1 | 2023 | 2050 | 0.120 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 202 | 0.110 |
Why?
|
Learning | 1 | 2023 | 1761 | 0.110 |
Why?
|
Infection Control | 1 | 2021 | 985 | 0.110 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2005 | 361 | 0.110 |
Why?
|
Pilot Projects | 2 | 2019 | 8731 | 0.110 |
Why?
|
Wavelet Analysis | 1 | 2013 | 56 | 0.110 |
Why?
|
Patient Discharge | 2 | 2023 | 3476 | 0.100 |
Why?
|
Burnout, Professional | 1 | 2021 | 712 | 0.100 |
Why?
|
Breast Feeding | 1 | 2020 | 1364 | 0.100 |
Why?
|
Diagnostic Imaging | 2 | 2024 | 3541 | 0.100 |
Why?
|
Incidental Findings | 1 | 2017 | 698 | 0.100 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26375 | 0.100 |
Why?
|
Pennsylvania | 1 | 2013 | 615 | 0.100 |
Why?
|
Health Expenditures | 1 | 2024 | 2395 | 0.090 |
Why?
|
Patients | 1 | 2018 | 909 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2022 | 6541 | 0.090 |
Why?
|
Low Back Pain | 1 | 2019 | 989 | 0.090 |
Why?
|
Socioeconomic Factors | 3 | 2021 | 7861 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5313 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2017 | 1094 | 0.080 |
Why?
|
Transplantation, Autologous | 1 | 2014 | 2127 | 0.080 |
Why?
|
Mastectomy, Segmental | 1 | 2014 | 961 | 0.080 |
Why?
|
Medical Oncology | 1 | 2021 | 2349 | 0.080 |
Why?
|
Chronic Disease | 1 | 2024 | 9379 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1427 | 0.070 |
Why?
|
Photometry | 1 | 2008 | 57 | 0.070 |
Why?
|
Anticoagulants | 1 | 2023 | 4843 | 0.070 |
Why?
|
Patient Compliance | 1 | 2017 | 2693 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10117 | 0.070 |
Why?
|
Academic Medical Centers | 3 | 2024 | 2783 | 0.070 |
Why?
|
Fiber Optic Technology | 1 | 2008 | 291 | 0.070 |
Why?
|
Quality Improvement | 1 | 2021 | 3858 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2014 | 9433 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2015 | 9063 | 0.060 |
Why?
|
Cell Membrane | 1 | 2005 | 3663 | 0.060 |
Why?
|
Oxidation-Reduction | 1 | 2012 | 2225 | 0.060 |
Why?
|
Spectrometry, Fluorescence | 1 | 2008 | 694 | 0.060 |
Why?
|
Internet | 1 | 2018 | 3107 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2820 | 0.060 |
Why?
|
Mouth Mucosa | 1 | 2008 | 437 | 0.060 |
Why?
|
Disease Progression | 2 | 2019 | 13646 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2412 | 0.060 |
Why?
|
Algorithms | 3 | 2022 | 14154 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12558 | 0.060 |
Why?
|
Demography | 2 | 2021 | 1642 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2022 | 59686 | 0.060 |
Why?
|
Health Personnel | 1 | 2018 | 3380 | 0.060 |
Why?
|
Catheter Ablation | 1 | 2017 | 2776 | 0.060 |
Why?
|
Survivors | 1 | 2014 | 2382 | 0.060 |
Why?
|
Outpatients | 2 | 2024 | 1604 | 0.050 |
Why?
|
Colombia | 1 | 2024 | 287 | 0.050 |
Why?
|
Electric Power Supplies | 1 | 2023 | 96 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 13020 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3781 | 0.050 |
Why?
|
Mouth Neoplasms | 1 | 2008 | 597 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11254 | 0.050 |
Why?
|
Electronics | 1 | 2023 | 317 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 41795 | 0.050 |
Why?
|
Prognosis | 2 | 2019 | 30022 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9510 | 0.050 |
Why?
|
Medicare | 1 | 2019 | 6881 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2012 | 2906 | 0.040 |
Why?
|
Ambulatory Care | 2 | 2024 | 2784 | 0.040 |
Why?
|
Kinetics | 3 | 2013 | 6333 | 0.040 |
Why?
|
Glucose | 1 | 2012 | 4352 | 0.040 |
Why?
|
Career Mobility | 1 | 2022 | 262 | 0.040 |
Why?
|
Models, Biological | 2 | 2013 | 9493 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2012 | 4526 | 0.040 |
Why?
|
Planning Techniques | 1 | 2018 | 81 | 0.040 |
Why?
|
Lactation | 1 | 2020 | 397 | 0.040 |
Why?
|
Markov Chains | 2 | 2012 | 977 | 0.040 |
Why?
|
Drainage | 1 | 2023 | 1184 | 0.040 |
Why?
|
Adnexa Uteri | 1 | 2017 | 40 | 0.040 |
Why?
|
Area Under Curve | 2 | 2012 | 1642 | 0.040 |
Why?
|
Image Enhancement | 1 | 2008 | 2894 | 0.040 |
Why?
|
Training Support | 1 | 2017 | 109 | 0.030 |
Why?
|
Microwaves | 1 | 2017 | 184 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10478 | 0.030 |
Why?
|
Radio Waves | 1 | 2017 | 254 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15872 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1727 | 0.030 |
Why?
|
Social Responsibility | 1 | 2018 | 384 | 0.030 |
Why?
|
Postpartum Period | 1 | 2022 | 1197 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2019 | 771 | 0.030 |
Why?
|
Workplace | 1 | 2020 | 872 | 0.030 |
Why?
|
Research | 1 | 2022 | 1981 | 0.030 |
Why?
|
Guinea Pigs | 1 | 2005 | 1309 | 0.030 |
Why?
|
Awareness | 1 | 2018 | 653 | 0.030 |
Why?
|
Swine | 1 | 2023 | 5994 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1215 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2022 | 1515 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13576 | 0.030 |
Why?
|
Specialization | 1 | 2017 | 781 | 0.030 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 3236 | 0.020 |
Why?
|
Pyruvic Acid | 1 | 2013 | 205 | 0.020 |
Why?
|
Health Services Research | 1 | 2019 | 1817 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2014 | 823 | 0.020 |
Why?
|
Animals | 4 | 2023 | 169337 | 0.020 |
Why?
|
Social Support | 1 | 2020 | 2191 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2005 | 1680 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 30200 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2022 | 15881 | 0.020 |
Why?
|
Critical Care | 1 | 2022 | 2716 | 0.020 |
Why?
|
Computer Simulation | 2 | 2013 | 6277 | 0.020 |
Why?
|
Health Promotion | 1 | 2021 | 2209 | 0.020 |
Why?
|
Cochlea | 1 | 2005 | 845 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2013 | 20224 | 0.020 |
Why?
|
Adolescent | 3 | 2024 | 89184 | 0.020 |
Why?
|
Signal Transduction | 1 | 2012 | 23631 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2022 | 3801 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2056 | 0.020 |
Why?
|
Models, Statistical | 2 | 2015 | 5099 | 0.020 |
Why?
|
Lactic Acid | 1 | 2013 | 1140 | 0.020 |
Why?
|
Optical Fibers | 1 | 2008 | 135 | 0.020 |
Why?
|
Mutation | 1 | 2012 | 30228 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2734 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4588 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3632 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2925 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3633 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2008 | 848 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14737 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3617 | 0.010 |
Why?
|
Pattern Recognition, Automated | 1 | 2011 | 998 | 0.010 |
Why?
|
Child | 2 | 2024 | 80891 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12870 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 10776 | 0.010 |
Why?
|
Models, Genetic | 1 | 2013 | 3442 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14784 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8506 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9636 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36510 | 0.010 |
Why?
|
Software | 1 | 2015 | 4453 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42650 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 60049 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13323 | 0.010 |
Why?
|
Computational Biology | 1 | 2012 | 3543 | 0.010 |
Why?
|
Equipment Design | 1 | 2008 | 3529 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 19022 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22296 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 17135 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15455 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16721 | 0.010 |
Why?
|
Mice | 1 | 2013 | 82017 | 0.000 |
Why?
|
Concepts
(250)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(97)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_